In addition, DNA damage processes are particularly characteristic of basal tumors, when compared to ER + tumors that have less genomic instability8,25,26, thus consistent with our observation of low overall protein expression of DNA-PKcs within the majority of ER + when compared to ER− breast cancers. The gene discussed is PRKDC; the disease is breast carcinoma.